Chronic kidney disease is a silent condition with few symptoms until it is advanced. It is now killing up to 45,000 people ...

A man in his 40s of Middle Eastern descent, with no prior medical history, presented with severe abdominal pain that had ...

Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses the screening process for chronic kidney disease.

Doctors at New York University say two new studies show that they are a significant step closer to making cross-species ...

Thiazolidinediones are medications that reduce blood glucose levels and are now used to help people with chronic kidney disease (CKD: defined as long-term damage to the kidneys that reduces their ...

Background: Among patients with focal segmental glomerulosclerosis (FSGS), proteinuria and kidney function decline may be ...

A new testing protocol identifies patients whose chest pain is heart-related even though their main heart arteries look ...

As people age, so do their kidneys.1 The average decline in renal function is approximately 1 mL/min/year after 30 years ...

A new study shows that when two common tests for kidney function give very different results, it may be a sign of serious ...

Chronic kidney disease (CKD) represents a global health issue with a high socioeconomic impact. Beyond a progressive decline of kidney function, patients with CKD are at increased risk of ...